Minerva Surgical, Inc. provided revenue guidance for the full year 2022. The company expects full year 2022 revenue in the range of $60 million to $63 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | 0.00% | 0.00% | -99.91% |
Jan. 03 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-99.91% | 8.88K | |
+10.11% | 126B | |
-5.93% | 11.33B | |
+6.07% | 9.27B | |
+37.46% | 5.5B | |
+8.53% | 3.45B | |
-8.69% | 2.81B | |
-6.38% | 2.08B | |
-10.91% | 2.09B | |
-23.21% | 1.78B |
- Stock Market
- Equities
- UTRS Stock
- News Minerva Surgical, Inc.
- Minerva Surgical, Inc. Provides Revenue Guidance for the Full Year 2022